Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA approves Adakveo to reduce vaso-occlusive crises in patients with sickle cell disease

Nov. 18, 2019

Shanghai De Novo studies DN-1508052-01 in phase I for advanced solid tumors

Nov. 18, 2019

Phase I trial studies Rocket's hematopoietic cell-based gene therapy for pyruvate kinase deficiency

Nov. 18, 2019

New SCD1 and SCD5 inhibitors presented by Yumanity Therapeutics

Nov. 18, 2019

Korean investigators disclose mTORC1 inhibitors

Nov. 18, 2019

Innate Tumor Immunity identifies NLRP3 agonists

Nov. 18, 2019

Nippon Chemiphar discloses xanthine oxidase inhibitors

Nov. 18, 2019

Japanese researchers patent TRPC3 and TRPC6 antagonists

Nov. 18, 2019

Institute for Translational Vaccinology tests RSV vaccine in phase I study

Nov. 18, 2019

First-in-human data for novel platelet glycoprotein IIb/IIIa inhibitor RUC-4 in patients with STEMI

Nov. 18, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...